NEW ANTIVIRAL DRUG TRIAZID. RESULTS OF FIRST PHASE OF CLINICAL TRIAL

NEW ANTIVIRAL DRUG TRIAZID. RESULTS OF FIRST PHASE OF CLINICAL TRIAL

The paper contains а results of the study of the pharmacokinetics, tolerability and safety of a new influenza drug Triazide in several dose regimens conducted on healthy volunteers. The convenient method for the determining the Triazide in blood plasma and urine by the HPLC have been proposed for th...

Full description

Bibliographic Details
Main Authors: E. G. Deyeva, Yu. I. Shevchik, A. A. Shaldghan, K. A. Zagorodnikova, A. A. Tumashov, A. V. Baklykov, S. K. Kotovskaya, O. N. Chupahin, V. N. Charushin, V. L. Rusinov, D. S. Kopchuk
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-01-01
Series:Разработка и регистрация лекарственных средств
Subjects:
triazide
influenza
clinical research
safety
pharmacokinetics
Online Access:https://www.pharmjournal.ru/jour/article/view/623

Internet

https://www.pharmjournal.ru/jour/article/view/623

Similar Items